Unknown

Dataset Information

0

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.


ABSTRACT:

SUBMITTER: Cameron D 

PROVIDER: S-EPMC5489700 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2799234 | biostudies-literature
| S-EPMC3494422 | biostudies-literature
| S-EPMC5585417 | biostudies-literature
| S-EPMC7103001 | biostudies-literature
| S-EPMC4176878 | biostudies-literature
| S-EPMC5824321 | biostudies-literature
| S-EPMC5834079 | biostudies-literature
| S-EPMC5634660 | biostudies-literature
| S-EPMC8317384 | biostudies-literature
| S-EPMC7255982 | biostudies-literature